Claim: The 2026 trial showed that people who maintained a lower dose of Tirzepatide after achieving their weight loss goals were able to keep the weight off.
Verdict: Correct (90% confidence)
Explanation: According to Medscape, new trial data from 2026 suggests that some patients were able to maintain meaningful weight loss after stepping down from the maximum dose of Tirzepatide. Healio also reports that adults who switched from higher doses to a lower 5 mg dose maintained 67.9% of their weight loss. These sources directly support the claim that a 2026 trial demonstrated the effectiveness of maintaining weight loss with a lower dose of Tirzepatide.